TCTR20210315003已完成1 期
Effects of sodium glucose co-transporter-2 inhibitor on atrial arrhythmia burden in patient with cardiovascular implantable electronic device: a randomized controlled trial
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 166
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Presence of dual chamber CIED (pacemaker or defibrillator) for at least 3 months, 2. Age > 18 years old, 3. Atrial high rate episode (AHRE) with atrial rate >170 beats per minute of more than 6 minutes, 4. Given informed consent
排除标准
- •1. Currently taking SGLT2i, 2. Permanent AF or long-standing persistent AF, 3. Estimated GFR <25 mL/min/1.73 m2, 4. Pregnant or lactation, 5. SBP <95mmHg or symptoms of hypotension, 6. Hospitalized, ACS, CABG, PCI, or cardioversion within 3 months, 7. Atrial arrhythmia ablation within previous 3 months or currently plan, 8. Bladder cancer, 9. History of genital infection within 3 months, 10. History of frequent urinary tract infection (UTI) (>=2 UTI in 6 months or >=3 UTI in 12 months), 11. DM type 1
研究者
相似试验
已完成
不适用
Effects of sodium-glucose co-transporter 2 inhibitor on metabolic parameters in patients with diabetes mellitusType 2 diabetesJPRN-UMIN000021584agoya University150
尚未招募
3 期
A clinical trial to study the effect of a drug,dapagliflozin in type 2 diabetic mellitus patient having diabetic macular edemaCTRI/2019/03/017915Postgraduate Institute of Medical Education and Research
尚未招募
4 期
Effects of SGLT2 Inhibitor Therapy on Pancreatic and hepatic fat content in patients of Type 2 Diabetes MellitusCTRI/2019/08/020909ASTRA ZENECA PHARMACEUTICAL INDIA
已完成
不适用
Sodium-glucose cotransporter 2 inhibition reduces body weight but not plasma glucose level in patients with type2 diabetes and mild renal failureJPRN-UMIN000038103Manda Memorial Hospital80
已完成
不适用
Effect of Sodium-Glucose Cotransporter-2 inhibitor in patients with type 2 daibetes mellitusJPRN-UMIN000014168Jichi Medical University82